Naviscan - LumaGEM MBI
by Naviscan
Naviscan - LumaGEM MBI
Follow Us
DESCRIPTION
Molecular Breast Imaging System
The LumaGEM® Molecular Breast Imaging system’s patented mounting mechanism allows the use of light breast immobilization for greater patient comfort during breast cancer imaging exam.
The LumaGEM MBI system for breast cancer imaging visually illuminates the enhanced metabolic activity in the breast associated with the occurrence of a tumor growth that is typically not visible on a digital mammogram due to tissue density and/or tumor size.
MBIs are extremely well tolerated by patients, as it’s a patient-friendly and a cost-effective tool for detecting hard to find small lesions in women who have dense breast tissue. When used as a secondary screening modality following digital mammography, the LumaGEM MBI system has increased breast cancer detection rates by almost 400% in early-stage invasive cancers.
FORUMSView All
FEATURES
- Clear resolution (high intrinsic spatial resolution, 1.6mm), the best available detector on the market
- Offers clinically high accuracy with Low false negatives (high sensitivity, 91%)2 and Low false positives (high specificity, 93%)2
- Knowing what is negative (Negative Predictive Value, 99.8%)2
- Proven/published lower dose capabilities minimizing patient risk (2.6mSv at 8 mCi)3,4
- Patient friendly, comfortable exam with minimal compression
- Alternative for women contraindicated for MRI due to pacemakers or other ferromagnetic implants, poor renal function, claustrophobia, and body size or gadolinium allergies
- Seamlessly integrates into workflow: Looks and acts like a mammography system with easy comparison to standard mammographic views (cranial caudal and mediolateral oblique)
Additional Specifications
Detector Configuration - Dual head
Detectors - Cadmium Zinc Telluride (CZT)
Typical Clinical Dose1 - 8 mCi (99mTc-Sestamibi)
Whole-Body Dose2,3 - 2.4mSv (at 8 mCi)
Intrinsic Spatial Resolution - 1.6mm
Energy Resolution: Full-Width Half-Maximum (FWHM) <5% (at 140 keV)
Sensitivity2 - 91% (with mammo)
Specificity2 - 93%
Collimator - Registered tungsten
Field-of-View - 16×20 cm2